HMS Assessment and Management of Hyperkalemia in the Hospital Setting: Optimizing Patient Outcomes Evaluation (ID: i753a-1) Survey

Question Title

* 2. How many years have you been in practice?

1 - 10

11 - 25

26 - 50

More than 50

Question Title

* 3. What is your degree?

PharmD

Other (please specify)

Question Title

* 4. How committed are you to making changes in your practice based on your participation in this activity?

Very committed

Committed

Neutral

Not committed

I do not plan to make changes

If not committed or do not plan to make changes, please indicate reason

Question Title

* 5. Which of the following best describes the impact of this activity on your performance?

I gained new strategies/skills/information I can apply to my area of practice

I need more information before I can change my practice

My practice is already consistent with the information presented

This activity will not change my practice

Question Title

* 6. What barriers do you see to making changes in your practice?

Lack of knowledge regarding evidence-based strategies

Lack of convincing evidence to warrant change

Lack of time/resources to consider change

Insurance, reimbursement or legal issues

Conflicting guidelines or evidence

Patient compliance and/or patient resource barriers

Other (please specify)

Question Title

* 7. After participating in today’s activity, I am now better able to:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Identify factors that increase risk for hyperkalemia	Identify factors that increase risk for hyperkalemia Strongly agree	Identify factors that increase risk for hyperkalemia Agree	Identify factors that increase risk for hyperkalemia Neutral	Identify factors that increase risk for hyperkalemia Disagree	Identify factors that increase risk for hyperkalemia Strongly disagree
Discuss the relationship between RAAS inhibitors and hyperkalemia development in patients with CKD, HF, HTN, and/or DM	Discuss the relationship between RAAS inhibitors and hyperkalemia development in patients with CKD, HF, HTN, and/or DM Strongly agree	Discuss the relationship between RAAS inhibitors and hyperkalemia development in patients with CKD, HF, HTN, and/or DM Agree	Discuss the relationship between RAAS inhibitors and hyperkalemia development in patients with CKD, HF, HTN, and/or DM Neutral	Discuss the relationship between RAAS inhibitors and hyperkalemia development in patients with CKD, HF, HTN, and/or DM Disagree	Discuss the relationship between RAAS inhibitors and hyperkalemia development in patients with CKD, HF, HTN, and/or DM Strongly disagree
Apply to practice an understanding of clinical trial evidence for the efficacy and safety of newer potassium binders approved for treating hyperkalemia	Apply to practice an understanding of clinical trial evidence for the efficacy and safety of newer potassium binders approved for treating hyperkalemia Strongly agree	Apply to practice an understanding of clinical trial evidence for the efficacy and safety of newer potassium binders approved for treating hyperkalemia Agree	Apply to practice an understanding of clinical trial evidence for the efficacy and safety of newer potassium binders approved for treating hyperkalemia Neutral	Apply to practice an understanding of clinical trial evidence for the efficacy and safety of newer potassium binders approved for treating hyperkalemia Disagree	Apply to practice an understanding of clinical trial evidence for the efficacy and safety of newer potassium binders approved for treating hyperkalemia Strongly disagree
Employ a multidisciplinary, team-based approach to improve outcomes for patients with hyperkalemia	Employ a multidisciplinary, team-based approach to improve outcomes for patients with hyperkalemia Strongly agree	Employ a multidisciplinary, team-based approach to improve outcomes for patients with hyperkalemia Agree	Employ a multidisciplinary, team-based approach to improve outcomes for patients with hyperkalemia Neutral	Employ a multidisciplinary, team-based approach to improve outcomes for patients with hyperkalemia Disagree	Employ a multidisciplinary, team-based approach to improve outcomes for patients with hyperkalemia Strongly disagree

Question Title

* 8. Bruce Spinowitz, MD, effectively:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Presented the material	Presented the material Strongly agree	Presented the material Agree	Presented the material Neutral	Presented the material Disagree	Presented the material Strongly disagree
Avoided commercial bias	Avoided commercial bias Strongly agree	Avoided commercial bias Agree	Avoided commercial bias Neutral	Avoided commercial bias Disagree	Avoided commercial bias Strongly disagree
The teaching and learning methods were effective	The teaching and learning methods were effective Strongly agree	The teaching and learning methods were effective Agree	The teaching and learning methods were effective Neutral	The teaching and learning methods were effective Disagree	The teaching and learning methods were effective Strongly disagree
The learning assessment used for this activity was appropriate	The learning assessment used for this activity was appropriate Strongly agree	The learning assessment used for this activity was appropriate Agree	The learning assessment used for this activity was appropriate Neutral	The learning assessment used for this activity was appropriate Disagree	The learning assessment used for this activity was appropriate Strongly disagree

Question Title

* 9. The content presented:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Enhanced my current knowledge base	Enhanced my current knowledge base Strongly agree	Enhanced my current knowledge base Agree	Enhanced my current knowledge base Neutral	Enhanced my current knowledge base Disagree	Enhanced my current knowledge base Strongly disagree
Addressed my most pressing questions	Addressed my most pressing questions Strongly agree	Addressed my most pressing questions Agree	Addressed my most pressing questions Neutral	Addressed my most pressing questions Disagree	Addressed my most pressing questions Strongly disagree
Promoted improvements or quality in health care	Promoted improvements or quality in health care Strongly agree	Promoted improvements or quality in health care Agree	Promoted improvements or quality in health care Neutral	Promoted improvements or quality in health care Disagree	Promoted improvements or quality in health care Strongly disagree
Was scientifically rigorous and evidence based	Was scientifically rigorous and evidence based Strongly agree	Was scientifically rigorous and evidence based Agree	Was scientifically rigorous and evidence based Neutral	Was scientifically rigorous and evidence based Disagree	Was scientifically rigorous and evidence based Strongly disagree
Avoided commercial bias or influence	Avoided commercial bias or influence Strongly agree	Avoided commercial bias or influence Agree	Avoided commercial bias or influence Neutral	Avoided commercial bias or influence Disagree	Avoided commercial bias or influence Strongly disagree

Question Title

* 10. If you indicated that you perceived commercial bias or influence, please describe:

Question Title

* 11. As a result of your participation in this activity, what is the one change you are most likely to implement in your practice?

Question Title

* 12. For pharmacists seeking ACPE credit, please provide

NABP #

Date of Birth (MM/DD)

Question Title

* 1. Contact Information

Question Title

* 2. How many years have you been in practice?

Question Title

* 3. What is your degree?

Question Title

* 4. How committed are you to making changes in your practice based on your participation in this activity?

Question Title

* 5. Which of the following best describes the impact of this activity on your performance?

Question Title

* 6. What barriers do you see to making changes in your practice?

Question Title

* 7. After participating in today’s activity, I am now better able to:

Question Title

* 8. Bruce Spinowitz, MD, effectively:

Question Title

* 9. The content presented:

Question Title

* 10. If you indicated that you perceived commercial bias or influence, please describe:

Question Title

* 11. As a result of your participation in this activity, what is the one change you are most likely to implement in your practice?

Question Title

* 12. For pharmacists seeking ACPE credit, please provide